Global Digital PCR and Real-time PCR Market Size, Share, Growth Analysis, By Product, By Technology(Digital PCR, and quantitative PCR ), By Application, By End-user

Description

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was valued at USD 5341.6 billion in 2021 and is poised to grow from USD 5806.48 billion in 2022 to USD 12018.88 billion by 2030, growing at a CAGR of 8.8% in the forecast period (2023-2030)

Real-time PCR and digital PCR are two widely used techniques for detecting and quantifying nucleic acids. Real-time PCR is a well-established technology that is known for its rapid and sensitive detection of nucleic acids in biological samples. Digital PCR, on the other hand, provides an absolute measure of target nucleic acid molecules by partitioning each sample into thousands of individual reactions.

The increasing prevalence of genetic and infectious diseases, as well as technological advancements in PCR, forensic, and other research laboratories, are driving the growth of the dPCR and qPCR market. However, technical limitations associated with PCR and the use of alternative assays to detect diseases may hinder market growth..

Segments covered in this report:

The Global digital PCR (dPCR) and real-time PCR (qPCR) market is segmented based on the product, technology, application, end-user, and region. Based on product, global digital PCR (dPCR) and real-time PCR (qPCR) market is segmented into reagents and consumables, instruments, and software. Based on technology, the digital PCR (dPCR) and real-time PCR (qPCR) market is segmented into digital PCR (dPCR), and quantitative PCR (qPCR). Based on application, the digital PCR (dPCR) and real-time PCR (qPCR) market is bifurcated into research applications, clinical applications, and forensic applications. Based on end-user, the digital PCR (dPCR) and real-time PCR (qPCR) market is bifurcated as hospitals & diagnostic centers, research laboratories & academic institutes, clinical research organizations, and others. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

The global digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow significantly during the forecast period, driven by the widespread prevalence of various infections, increasing genetic disorders, and the successful completion of the Human Genome Project. Digital PCR and real-time PCR are powerful molecular biology techniques that can be used to detect and quantify nucleic acids, the genetic material of cells. These techniques are used in a wide range of applications, including clinical diagnostics, research, and forensics. The increasing prevalence of infectious diseases is a major driver of the dPCR and qPCR market. These diseases include HIV/AIDS, malaria, tuberculosis, and influenza. Digital PCR and real-time PCR can be used to rapidly and accurately detect these diseases, which is essential for early diagnosis and treatment. Increasing genetic disorders is another major driver of the dPCR and qPCR market. These disorders include cystic fibrosis, sickle cell anemia, and Tay-Sachs disease. Digital PCR and real-time PCR can be used to diagnose these disorders, as well as to track the effectiveness of treatments. The successful completion of the Human Genome Project has also led to increased demand for digital PCR and real-time PCR. The Human Genome Project has provided a wealth of information about human genetics, which can be used to develop new diagnostic and therapeutic applications for digital PCR and real-time PCR.

Restraint

The technical limitations of dPCR and qPCR techniques, such as the need for signal measurement during the exponential phase of the PCR reaction and the optimization and validation of assay procedures, may hinder market growth. These limitations could lead to target detection failures due to reaction constraints or the inability to examine target molecules.

Key Market Trend

The increasing number of patients with viral infections has led to the development of digital PCR techniques to discover drugs or biomarkers for these diseases. Digital PCR techniques have also been improved to detect rare cancer biomarkers. Researchers can use digital droplet PCR (ddPCR) along with molecular biology techniques to identify new cancer biomarkers.

Product Code: SQMIG35J2038

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product

Market Overview
Reagents and consumables
instruments
and software

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Technology

Market Overview
Digital PCR (dPCR)
and quantitative PCR (qPCR)

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Application

Market Overview
Research applications
clinical applications
and forensic applications

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by End-user

Market Overview
Hospitals & diagnostic centers
research laboratories & academic institutes
clinical research organizations
and others

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Analytik Jena AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioFire Diagnostics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

Global Digital PCR and Real-time PCR Market Size, Share, Growth Analysis, By Product, By Technology(Digital PCR, and quantitative PCR ), By Application, By End-user - Industry Forecast 2023-2030